Concepedia

Ariel Teper

AT

Statistics

Publications

5

Citations

99

H-Index

5

Active since

2022

Affiliations

Insmed (United States)(Current)

Ninewells Hospital

University of Dundee

University of Connecticut

Ariel Teper is an author at Insmed (United States) specializing in pharmacology, clinical pharmacology, and pulmonary exacerbations.

Publications per year

2022–2025

5

Publications

5

Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics

James D. Chalmers, Pierre‐Régis Burgel, Charles L. Daley et al. · ERJ Open Research · 2024 · 32 citations · Full text

, , +14

Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis

James D. Chalmers, H. Usansky, Christopher M. Rubino et al. · Clinical Pharmacokinetics · 2022 · 24 citations · Full text

, , +16

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial

Emma D Johnson, Merete Long, Lídia Perea et al. · American Journal of Respiratory and Critical Care Medicine · 2025 · 18 citations

, , +17

Safety, Tolerability, and Pharmacokinetic Evaluation of Single and Multiple Doses of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Healthy Japanese and White Adults

H. Usansky, E. Yoon, Ariel Teper et al. · Clinical Pharmacology in Drug Development · 2022 · 15 citations · Full text

, , +12

Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis

James D. Chalmers, Mark L. Metersky, Joseph Feliciano et al. · ERJ Open Research · 2023 · 10 citations · Full text

, , +9

1–5 of 5